Albright Hereditary Osteodystrophy Trial
600
about 28 years
0.166666666666667–89
1 site in CT
What this study is about
Researchers are testing the natural history of Albright hereditary osteodystrophy, which includes pseudohypoparathyroidism type 1A. The trial also evaluates neurocognitive and psychosocial functioning in participants with AHO to understand common impairments and guide management strategies. It involves assessing growth hormone deficiency and response to treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Neurocognitive and psychosocial testing
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: PHP1A: Effect of GH on height, growth velocity, final height in children. Effect on weight, BMI, lipids, BMD, self-esteem in all ages.